Skip to content

Assessing the effect of kokilaksha kashaya with and without kaishora guggulu in the management of vatarakta with specific reference to Gouty Arthritis;A randomised clinical trail.

An open lebel comparative clinical study to evaluate the effect of kokilaksha kashaya with and without kaishora guggulu in the management of vatarakta with specific reference to Gouty Arthritis. - NIL

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/04/083918
Enrollment
40
Registered
2025-04-02
Start date
Unknown
Completion date
Unknown
Last updated
2025-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: 7- Osteopathic

Interventions

None listed

Sponsors

DR JYOTI MARUTI SAYANAK
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients having cardinal signs and symptoms of Vatarakta are Sandi Shoola, Sandi Shotha, Vaivarnya, Sthambana, Chimchimayana, Sheeta pradwesha, Ugradaha, Sankoch of dhamani, anguli and Sandi. 2.On irregular medications and irrespective of discrimination of race, religion and sex. 3.Patients fulfilling the diagnostic criteria of Vatarakta preferred serum uric acid above 7.5mg/dl to 15mg/dl.

Exclusion criteria

Exclusion criteria: 1.patients with diabetes mellitus, hypertension, congenital abnormalities. 2. Unstable medical or psychiatric illness. 3 history of seizures. 4. Pregnant women, lactating mother and alcoholic. 5 symptoms suggestive of Vatavyadhi other than Vatarakta. 6.Vatarakta with Upadrava. 7. Patient having serum uric acid less than 3.5 mg/dl and more than 15mg/dl

Design outcomes

Primary

MeasureTime frame
Reduction in sandishoola/severity of joint pain measuredwith VAS Scale Reduction in Sandi Shotha measured in cms Improvement in the range of movements of joints measured with Goniometer readingTimepoint: 1st day i.e before treatment, 15th day after giving treatment and on 30th day i.e 4 weeks.

Secondary

MeasureTime frame
Improvement in the overall signs and symptoms of Vatarakta and improvement in the quality of life.Timepoint: 1st day i.e before treatment Follow up 15th day after treatment and on 31 st day after treatment

Countries

India

Contacts

Public ContactDr Roopa Bhat

Dhanwantari Ayurveda College Hospital and PG Research Centre Siddapur

ayurroopa@gmail.com9845301333

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026